Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
45.49
-0.51 (-1.11%)
At close: Jan 16, 2026
51.58% (1Y)
| Market Cap | 30.55B |
| Revenue (ttm) | 5.37B |
| Net Income (ttm) | 3.58B |
| Shares Out | 770.09M |
| EPS (ttm) | 4.66 |
| PE Ratio | 9.77 |
| Forward PE | 15.06 |
| Dividend | 1.28 (2.81%) |
| Ex-Dividend Date | Jul 4, 2025 |
| Volume | 3,859,568 |
| Average Volume | 3,923,630 |
| Open | 45.84 |
| Previous Close | 46.00 |
| Day's Range | 45.33 - 46.24 |
| 52-Week Range | 28.53 - 50.97 |
| Beta | 0.85 |
| RSI | 42.81 |
| Earnings Date | Mar 31, 2026 |